Ponction échoguidée de kyste biliaire et pancréatique à Pointe-Noire en 2015

Biochemical and resistance profile of Helicobacter pylori isolated in N’Djamena in Chad

“…It would be related to its prescription in respiratory infections when an atypical germ is suspected16 . This resistance rate was different from those of Bouihat in Morocco in 201722 , Dia et al in Dakar in 200819 , and Naïma in 2018 in Algeria 17 , who had not obtained resistance to amoxicillin. The CNRCH reported in its 2019 activity report a resistance of 2% in France33 .…”

“…However, was similar to that of Ben Mansour et al, Who reported 15.4% in Tunisia in 2010 15 , to that of Tanih et al, Who obtained 20% in South Africa in 2013 30 . It was much lower than that of Raymond et al, Who found 26% in France in 201031 , that of Bouihat who reported 28.6% in Morocco in 201722 , and that of Djennane-Hadibi et al, Who obtained 33% in Algeria in 201632 . In 2010, primary resistance to clarithromycin was 17.2% worldwide.…”

“…These data were comparable to those of Joutei et al, who obtained 53% for women, 47% for men in Morocco in 200726 , and to those of Bouihat who obtained 65.21% in the group of men. and 72.8% in the group of women in Morocco in 201722 . Firmin et al, obtained 78.6% in the group of men and 68.3% in the group of women in Yaoundé, Cameroon in 2013 21 .…”

“…This resistance rate was superimposed on that of Bouihat and Kalach, but higher than that of Naïma and Ontsira. Bouihat had obtained a resistance rate of 10.7% to levofloxacin in Morocco in 201722 , Kalach had found 13.2% in France in 2007 14 , Ontsira had obtained 1.2% in Congo Brazzaville in 2016 28 , and Naïma reported 2% in Algeria in 2018 17 . The CNRCH had reported in its annual activity report for 2019 a resistance rate of 19.1% for Levofloxacin in France 33 .…”